학술논문
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Document Type
Article
Author
Day, T.A.; Vergara, J.; Rolf, T.A.; Ashman, J.; Frevol, A.; Sagawa, Z.K.; Reed, S.G.; Coler, R.N.; Penn-Nicholson, A.; Luabeya, A.K.K.; Reid, T.D.; Toefy, A.; Shenje, J.; Geldenhuys, H.; Tameris, M.; Mabwe, S.; Bilek, N.; Scriba, T.J.; Hatherill, M.; Bekker, L.-G.; Fiore-Gartland, A.; Du Plessis, N.; Loxton, A.G.; Walzl, G.; Diacon, A.; Lindestam Arlehamn, C.; Sette, A.; Beckmann, A.M.; Hsu, F.-C.; Albertson, S.; Veldsman, A.; Schreuder, C.; Smit, E.; Cloete, Y.; Ontong, C.; Filander, E.; Jacobs, G.; Keyser, A.; Africa, H.; Mulenga, H.; Noble, J.; Makhethe, L.; Steyn, M.; de Kock, M.; Quaqua, N.; Lu, Y.; Gutschmidt, A.; Thienneman, F.; Kahn, S.; Mouton, A.; Van Rooyen, E.; Opperman, F.; Swarts, A.; Van Schalkwyk, A.; Herselman, Y.; Hofmeester, D.; Amsterdam, J.; Hassanally, L.; van der Merwe, L.; Companie, A.; Rossouw, S.; Jones, C.; Botes, N.; van der Riet, E.; Goliath, S.; Kruger, S.; Sinandile, E.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, April 2021, 9(4):373-386)
Subject
Language
English
ISSN
22132619
22132600
22132600